Engineers Gate Manager LP Durect Corp Transaction History

Engineers Gate Manager LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.43 - $5.9 $5,740 - $78,759	-13,349 Reduced 55.0%	10,921 $6,000
Q2 2022 Aug 15, 2022	SELL	$0.38 - $0.64 $82 - $138	-216 Reduced 0.88%	24,270 $12,000
Q4 2021 Feb 14, 2022	BUY	$0.9 - $1.31 $180 - $262	200 Added 0.82%	24,486 $24,000
Q3 2021 Nov 15, 2021	BUY	$1.21 - $1.61 $182 - $243	151 Added 0.63%	24,286 $31,000
Q2 2021 Aug 16, 2021	SELL	$1.6 - $2.02 $1,120 - $1,414	-700 Reduced 2.82%	24,135 $39,000
Q1 2021 May 17, 2021	SELL	$1.86 - $2.87 $6,117 - $9,439	-3,289 Reduced 11.69%	24,835 $49,000
Q4 2020 Feb 16, 2021	SELL	$1.65 - $2.43 $172,703 - $254,345	-104,669 Reduced 78.82%	28,124 $58,000
Q3 2020 Nov 16, 2020	BUY	$1.6 - $2.35 $212,468 - $312,063	132,793 New	132,793 $227,000
Q1 2020 May 15, 2020	SELL	$0.97 - $2.85 $18,059 - $53,061	-18,618 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.69 - $3.8 $11,459 - $25,767	6,781 Added 57.29%	18,618 $71,000
Q3 2019 Nov 14, 2019	BUY	$0.61 - $2.21 $7,220 - $26,159	11,837 New	11,837 $22,000
Q2 2018 Aug 03, 2018	SELL	$1.56 - $2.51 $159,034 - $255,881	-101,945 Closed	0 $0
Q1 2018 May 07, 2018	BUY	$0.91 - $2.24 $92,769 - $228,356	101,945 New	101,945 $218,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $173M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.